Hip
Senior Member
- Messages
- 18,131
This Reddit post details an 80-90% recovery from long COVID ME/CFS, achieved from melatonin at a high dose of 15-20 mg daily. In a PM he told me he takes three divided doses of 5 mg in the morning, 5 mg in the afternoon, and 5 mg at night.
He said he was drowsy and sleepy for 3 days when he first started daytime melatonin, but then started getting used to it. He said he drank coffee to counter the sleepiness, and that helped.
His ME/CFS was between moderate and severe, but after following this melatonin protocol for three months, he went into near remission.
However, his long COVID ME/CFS was somewhat unusual, in that he was constantly catching colds and infections, which hit him severely, and were always setting his ME/CFS back to square one.
Before melatonin, he would get a new cold every 2-3 weeks, and this meant he would be in bed for 7-10 days due to the infection, and then have 1-2 weeks to recover, until a new infection would come along and put him back to being bedridden again.
But after starting melatonin, this protected him from severe colds, so his ME/CFS was not being constantly set back by these viral infections. When he catches a cold, he says he increases his melatonin dose to 30-60 mg daily, and finds he now recovers from the cold within 1-3 days, and finds the colds are now very mild and barely noticeable.
He thinks these constant severe colds were preventing his recovery from ME/CFS, and he credits the high-dose melatonin taken day and night with preventing these colds from becoming severe.
He says the severe colds he was constantly getting were definitely due to COVID, because before catching COVID, he only caught colds once or twice a year.
So this melatonin treatment might be good for the sort of ME/CFS patients who are always catching colds, and who find these colds hit them very hard, and cause lingering ill effects which constantly set back their ME/CFS.
According to a poll, most ME/CFS patients are the type who have ramped up immunity, so that they rarely catch colds (Rich Van Konynenburg had a theory of why this subtype of ME/CFS is immune to colds).
But the poll indicates that 15% of patients are the opposite, the type that has weakened immunity that makes them catch colds all the time, with each cold hitting them extremely hard, and with it taking them weeks or months to fully recover and get back to baseline.
It is for this latter subtype that this very high-dose melatonin protocol might work.
Melatonin is synthesised in the brain's pineal gland at night for the purpose of inducing sleep, but it is also synthesised in the rest of the body, where its benefits include its potent antioxidant capabilities and immune regulation.
Note that melatonin has a short plasma half-life of only 40 minutes, so it leaves the body quickly. Thus if taken only at night before bed, melatonin will have mostly disappeared from the body after about 3 hours.
Thus the key feature of this protocol may be that he takes melatonin three times daily, which exposes his body to melatonin for longer periods.
He lists the following studies as those he read about the benefits of melatonin:
General benefits:
https://pmc.ncbi.nlm.nih.gov/articles/PMC6453953/
https://pmc.ncbi.nlm.nih.gov/articles/PMC3645767/
Specific benefits for COVID:
https://pmc.ncbi.nlm.nih.gov/articles/PMC10043401/
https://pmc.ncbi.nlm.nih.gov/articles/PMC9687267/
https://pmc.ncbi.nlm.nih.gov/articles/PMC10852014/
https://pmc.ncbi.nlm.nih.gov/articles/PMC7985934/
General antiviral effects:
https://pmc.ncbi.nlm.nih.gov/articles/PMC7169144/
https://pmc.ncbi.nlm.nih.gov/articles/PMC7405774/
I asked perplexity.ai to summarise the benefits mentioned in these studies, and this is the response:
I also came across this study showing how in mice, very high-dose melatonin was able to ameliorate coxsackievirus B myocarditis infection. This mouse study used 14.4 mg/kg of melatonin as a coxsackievirus B3 myocarditis treatment. The equivalent human dose would be 100 mg of melatonin.
He said he was drowsy and sleepy for 3 days when he first started daytime melatonin, but then started getting used to it. He said he drank coffee to counter the sleepiness, and that helped.
His ME/CFS was between moderate and severe, but after following this melatonin protocol for three months, he went into near remission.
However, his long COVID ME/CFS was somewhat unusual, in that he was constantly catching colds and infections, which hit him severely, and were always setting his ME/CFS back to square one.
Before melatonin, he would get a new cold every 2-3 weeks, and this meant he would be in bed for 7-10 days due to the infection, and then have 1-2 weeks to recover, until a new infection would come along and put him back to being bedridden again.
But after starting melatonin, this protected him from severe colds, so his ME/CFS was not being constantly set back by these viral infections. When he catches a cold, he says he increases his melatonin dose to 30-60 mg daily, and finds he now recovers from the cold within 1-3 days, and finds the colds are now very mild and barely noticeable.
He thinks these constant severe colds were preventing his recovery from ME/CFS, and he credits the high-dose melatonin taken day and night with preventing these colds from becoming severe.
He says the severe colds he was constantly getting were definitely due to COVID, because before catching COVID, he only caught colds once or twice a year.
So this melatonin treatment might be good for the sort of ME/CFS patients who are always catching colds, and who find these colds hit them very hard, and cause lingering ill effects which constantly set back their ME/CFS.
According to a poll, most ME/CFS patients are the type who have ramped up immunity, so that they rarely catch colds (Rich Van Konynenburg had a theory of why this subtype of ME/CFS is immune to colds).
But the poll indicates that 15% of patients are the opposite, the type that has weakened immunity that makes them catch colds all the time, with each cold hitting them extremely hard, and with it taking them weeks or months to fully recover and get back to baseline.
It is for this latter subtype that this very high-dose melatonin protocol might work.
Melatonin is synthesised in the brain's pineal gland at night for the purpose of inducing sleep, but it is also synthesised in the rest of the body, where its benefits include its potent antioxidant capabilities and immune regulation.
Note that melatonin has a short plasma half-life of only 40 minutes, so it leaves the body quickly. Thus if taken only at night before bed, melatonin will have mostly disappeared from the body after about 3 hours.
Thus the key feature of this protocol may be that he takes melatonin three times daily, which exposes his body to melatonin for longer periods.
He lists the following studies as those he read about the benefits of melatonin:
General benefits:
https://pmc.ncbi.nlm.nih.gov/articles/PMC6453953/
https://pmc.ncbi.nlm.nih.gov/articles/PMC3645767/
Specific benefits for COVID:
https://pmc.ncbi.nlm.nih.gov/articles/PMC10043401/
https://pmc.ncbi.nlm.nih.gov/articles/PMC9687267/
https://pmc.ncbi.nlm.nih.gov/articles/PMC10852014/
https://pmc.ncbi.nlm.nih.gov/articles/PMC7985934/
General antiviral effects:
https://pmc.ncbi.nlm.nih.gov/articles/PMC7169144/
https://pmc.ncbi.nlm.nih.gov/articles/PMC7405774/
I asked perplexity.ai to summarise the benefits mentioned in these studies, and this is the response:
Immunomodulatory Effects
Melatonin acts as an immune buffer, providing both immunostimulant and anti-inflammatory properties depending on the immune conditions. This dual action allows melatonin to:
- Stimulate the immune system under basal or immunosuppressive conditions
- Act as an anti-inflammatory compound during exacerbated immune responses, such as acute inflammation
Antiviral Properties
Melatonin has shown promising antiviral effects against various viral infections:
- It exhibits antiviral activity against respiratory syncytial virus (RSV) by suppressing RSV-induced inflammation and oxidative stress
- Melatonin can inhibit viral infections by reducing virus-induced oxidative stress and inflammatory responses
- It has been shown to have antiapoptotic effects, potentially protecting cells from virus-induced cell death
- Melatonin can modulate autophagy, a cellular process that plays a role in viral replication and host defense
- Its ability to cross physiological barriers, including the blood-brain barrier, allows for potential neuroprotective effects during viral infections affecting the nervous system
COVID-19 Potential
Several studies have explored melatonin's potential in combating COVID-19:
- Melatonin may help reduce the severity of COVID-19 by suppressing cytokine storms and oxidative stress
- It has been suggested as a potential adjuvant therapy for COVID-19 due to its anti-inflammatory, antioxidant, and immune-enhancing properties
Oxidative Stress Reduction
One of melatonin's key benefits is its potent antioxidant activity:
- It acts as a free radical scavenger, protecting cells from oxidative damage
- Melatonin enhances the production of antioxidant enzymes, further bolstering cellular defenses against oxidative stress
Anti-inflammatory Action
Melatonin's anti-inflammatory properties contribute to its potential therapeutic effects:
- It can suppress the production of pro-inflammatory cytokines
- Melatonin modulates the NF-κB signaling pathway, which plays a crucial role in inflammation
Sleep Regulation
As a well-known sleep aid, melatonin's benefits extend to immune function:
- Proper sleep is essential for maintaining a robust immune system
- Melatonin's sleep-promoting effects may indirectly support the body's ability to fight viral infections
I also came across this study showing how in mice, very high-dose melatonin was able to ameliorate coxsackievirus B myocarditis infection. This mouse study used 14.4 mg/kg of melatonin as a coxsackievirus B3 myocarditis treatment. The equivalent human dose would be 100 mg of melatonin.
Last edited: